Management of major bleeding outcomes under antithrombotic therapy in real-life

Bleeding is the most serious undesirable event of antithrombotic therapy, though this treatment has shown benefits in terms of venous or arterial thrombosis prevention, particularly in case of atrial fibrillation, stroke, venous thromboembolism, and coronary disease.

Source: Thrombosis Research - January 9, 2020 Category: Hematology Authors: F. Moustafa, A. Corriger, C. Lambert, A. Barres, C. Camminada, D. Teissandier, J. Saint-Denis, F. Dutheil, J. Schmidt Tags: Letter to the Editors-in-Chief Source Type: research